Nina Lapke

3F, No.345, Xinhu 2nd Rd, 114
Neihu, TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Genetic alterations and their therapeutic implications in epithelial ovarian cancer.

Genetic alterations and their therapeutic implications in epithelial ovarian cancer.

Journal: BMC cancer
Published: July 14, 2020

Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.

Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.

Journal: Case reports in oncological medicine
Published: July 09, 2019

TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer.

TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer.

Journal: Cancers
Published: July 08, 2019

Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer.

Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer.

Journal: Case reports in oncological medicine
Published: February 11, 2019

PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.

PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.

Journal: Cancers
Published: July 12, 2018

Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer.

Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer.

Journal: Molecular cancer therapeutics
Published: December 30, 2017

Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification.

Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 24, 2017

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.

Journal: Oncotarget
Published: August 20, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026